Tirzepatide 20mg Australia 10 Pack | Research use ONLY Peptide

Product Description

Tirzepatide is a synthetic peptide compound studied in laboratory research for its interaction with incretin-related pathways and metabolic signalling mechanisms. Research investigations have examined Tirzepatide in relation to receptor activity, glucose metabolism pathways, and broader metabolic science applications.

This Tirzepatide 20mg 10-pack is supplied as a lyophilised research peptide intended exclusively for laboratory and analytical research purposes. Each vial contains 20mg of peptide material suitable for controlled research environments requiring documented specifications and quality verification.

Product Specifications

• Peptide: Tirzepatide
• Strength: 20mg per vial
• Pack Size: 10 vials
• Form: Lyophilised powder
• Purity: >98%
• Verification: Certificate of Analysis (COA) supplied
• Testing: Independent third-party laboratory testing in Australia
• Storage: Store at 2–8°C according to research compound storage recommendations

Research Applications

Tirzepatide has been studied within scientific research settings involving:

• Incretin receptor pathway investigations
• Peptide signalling research
• Metabolic pathway studies
• Laboratory analysis of synthetic peptide compounds

Quality Assurance

Silverback Peptides supplies research compounds with supporting documentation, including batch-specific analytical data and quality verification for researchers conducting peptide-related studies.

Research Use Only Notice

This product is supplied strictly for research use only. It is not intended for human consumption, therapeutic use, diagnostic purposes, or medical application.